Literature DB >> 29325797

Consequences of Retained Defibrillator and Pacemaker Leads After Heart Transplantation-An Underrecognized Problem.

Luise Holzhauser1, Teruhiko Imamura1, Hemal M Nayak1, Nitasha Sarswat1, Gene Kim1, Jayant Raikhelkar1, Sara Kalantari1, Amit Patel1, David Onsager2, Tae Song2, Takeyoshi Ota2, Valluvan Jeevanandam2, Gabriel Sayer1, Nir Uriel3.   

Abstract

BACKGROUND: Cardiovascular implantable electronic devices (CIEDs) are common in patients undergoing heart transplantation (HT), and complete removal is not always possible at the time of transplantation.
METHODS: We retrospectively assessed the frequency of retained CIED leads and clinical consequences in consecutive HT patients from 2013 to 2016. Clinical outcomes included bacteremia, upper-extremity deep venous thrombosis (UEDVT), lead migration, and inability to perform magnetic resonance imaging (MRI).
RESULTS: A total of 138 patients (55 ± 11 years of age, 76% male) were identified; 37 (27%) had retained lead fragments (RLFs) at discharge. Patients with RLFs were older, had longer lead implantation time before HT, and a higher prevalence of dual-coil CIED leads compared with those without RLFs (P < .05 for all). Lead implantation time was identified as an independent predictor for RLFs (P < .05). Patients with RLFs had a higher frequency of DVT compared with the non-RLF group during the 1-year study period (42% vs 21%; P < .04). There was no difference in bacteremia. Fourteen patients (38%) could not undergo clinically indicated MRI.
CONCLUSION: RLFs after HT occur commonly and are associated with a higher rate of UEDVT and limit the use of MRI. Although no significant difference was found in the rates of bacteremia between the groups, this finding might be explained by the overall low incidence. Patients with risk factors for RLFs should be identified before transplantation, and complete lead removal should be considered with a multidisciplinary approach.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart transplantation; deep venous thrombosis (DVT); magnetic resonance imaging (MRI); retained ICD leads

Mesh:

Year:  2018        PMID: 29325797      PMCID: PMC5945281          DOI: 10.1016/j.cardfail.2017.12.012

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  33 in total

1.  Sirolimus may promote thrombotic microangiopathy.

Authors:  Jocelyne A Saikali; Luan D Truong; Wadi N Suki
Journal:  Am J Transplant       Date:  2003-02       Impact factor: 8.086

2.  Platelet activation in heart transplant recipients.

Authors:  Aina Hognestad; Annika Michelsen; Frank Brosstad; Jan K Damås; Torbjørn Holm; Svein Simonsen; John K Kjekshus; Pål Aukrust; Arne K Andreassen
Journal:  Clin Transplant       Date:  2004-04       Impact factor: 2.863

3.  Immunosuppressants accelerate microvascular thrombus formation in vivo: role of endothelial cell activation.

Authors:  Anja Püschel; Nicole Lindenblatt; Juliane Katzfuss; Brigitte Vollmar; Ernst Klar
Journal:  Surgery       Date:  2011-10-22       Impact factor: 3.982

4.  Incidence of complications in patients with implantable cardioverter/defibrillator who receive additional transvenous pace/sense leads.

Authors:  Christian G Wollmann; Dirk Böcker; Andreas Löher; Julia Köbe; Hans H Scheld; Günter E Breithardt; Rainer Gradaus
Journal:  Pacing Clin Electrophysiol       Date:  2005-08       Impact factor: 1.976

5.  Pacemaker lead tip heating in abandoned and pacemaker-attached leads at 1.5 Tesla MRI.

Authors:  Deborah A Langman; Ira B Goldberg; J Paul Finn; Daniel B Ennis
Journal:  J Magn Reson Imaging       Date:  2011-02       Impact factor: 4.813

Review 6.  Clinical practice. Deep-vein thrombosis of the upper extremities.

Authors:  Nils Kucher
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

7.  Post heart transplant extraction of the abandoned fragments of pacing and defibrillation leads: proposed management algorithm.

Authors:  Krzysztof Kuśmierski; Andrzej Przybylski; Artur Oręziak; Małgorzata Sobieszczańska-Małek; Piotr Kołsut; Jacek Różański
Journal:  Kardiol Pol       Date:  2013       Impact factor: 3.108

8.  Frequency and sequelae of retained implanted cardiac device material post heart transplantation.

Authors:  Andrew Martin; Jamie Voss; Duncan Shannon; Peter Ruygrok; Nigel Lever
Journal:  Pacing Clin Electrophysiol       Date:  2014-01-15       Impact factor: 1.976

9.  Do abandoned leads pose risk to implantable cardioverter-defibrillator patients?

Authors:  Michael Glikson; Mahmoud Suleiman; David M Luria; Marjorie L Martin; David O Hodge; Win-Kuang Shen; David J Bradley; Thomas M Munger; Robert F Rea; David L Hayes; Stephen C Hammill; Paul A Friedman
Journal:  Heart Rhythm       Date:  2008-10-11       Impact factor: 6.343

10.  Alterations in the fibrinolytic cascade post-transplant: evidence of a bimodal expression pattern.

Authors:  Raymond L Benza; Matthew A Cavender; Joseph Barchue; Jose A Tallaj; Robert C Bourge; James K Kirklin; Christopher S Coffey
Journal:  J Heart Lung Transplant       Date:  2007-05       Impact factor: 10.247

View more
  2 in total

1.  Implantable cardioverter-defibrillator in patients awaiting heart transplantation: Reinforcing the bridge to transplant.

Authors:  Jonathan P Ariyaratnam; Michael B Stokes; Dennis H Lau
Journal:  Heart Rhythm O2       Date:  2021-12-17

2.  Safety of MRI in patients with retained cardiac leads.

Authors:  Bach T Nguyen; Bhumi Bhusal; Amir Ali Rahsepar; Kate Fawcett; Stella Lin; Daniel S Marks; Rod Passman; Donny Nieto; Richard Niemzcura; Laleh Golestanirad
Journal:  Magn Reson Med       Date:  2021-12-27       Impact factor: 3.737

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.